However, the volume and severity of recent complaints have escalated concerns about legal accountability for unsafe and misbranded versions of GLP-1 drugs
Studies suggest these medications may calm inflammatory cytokines the chemical messengers that drive inflammation in conditions like rheumatoid arthritis and lupus
Across these studies, the notion of food aversion and nausea through GLP-1 signaling has been implied, but there lacks sufficient evidence to support this claim [56]
Obesity is the biggest risk factor for Type 2 diabetes, and substantial weight loss can help in reversal and remission of the disease, as well as reduced risk for conditions like high blood pressure, dyslipidemia, heart disease, and stroke
Patients with pre-existing GERD should be counseled about potential symptom exacerbation and monitored appropriately during GLP-1 initiation